4.7 Review

L-Arginine and COVID-19: An Update

期刊

NUTRIENTS
卷 13, 期 11, 页码 -

出版社

MDPI
DOI: 10.3390/nu13113951

关键词

antiviral therapies; arginine; cytokine storm; coronavirus; COVID-19; endothelium; immune response; immunity; inflammation; nitric oxide; nitrosylation; oxidative stress; ROS; SARS-CoV-2; T cells; viral infections

资金

  1. National Institutes of Health (NIH) [R01HL146691, R01-DK123259, R01-HL159062, R01-DK033823, R56-AG066431, T32-HL144456, R00DK107895]
  2. Irma T. Hirschl Trust
  3. Monique-Weill-Caulier Trust
  4. Diabetes Action Research and Education Foundation
  5. American Heart Association [AHA-21POST836407, AHA-20POST35211151]

向作者/读者索取更多资源

L-Arginine may play a crucial role in COVID-19 by affecting endothelial cells and the immune system, and could potentially serve as a therapeutic tool based on recent clinical experimentations.
L-Arginine is involved in many different biological processes and recent reports indicate that it could also play a crucial role in the coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Herein, we present an updated systematic overview of the current evidence on the functional contribution of L-Arginine in COVID-19, describing its actions on endothelial cells and the immune system and discussing its potential as a therapeutic tool, emerged from recent clinical experimentations.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据